EUVIMEDEUVIMED entdecken
Open Access

Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination

Michael D Frakes, Melissa F Wasserman

American Economic Journal: Economic Policy · 01.08.2023 · 15 (3) · 151-183

DOI: 10.1257/pol.20200703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Economic Journal: Economic Policy, erschienen am 01.08.2023. Verfasst von Michael D Frakes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Duke University, 210 Science Drive, PO Box 90362, Durham, NC 27708. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We explore how the U.S. Patent and Trademark Office may improve the quality of issued patents on “secondary” drug features by giving examiners more time to review drug patent applications. Our findings suggest that current time allocations are causing examiners to issue low-quality secondary patents on the margin. To assess the merits of expanding ex ante scrutiny of drug patent applications at the agency, we set forth estimates of the various gains and losses associated with giving examiners more time, including reduced downstream litigation costs and added personnel expenses, along with both the static gains and dynamic innovation losses associated with earlier generic entry. (JEL K11, L65, O31, O34, O38)

Autor:innen und Institutionen

  • Duke University, 210 Science Drive, PO Box 90362, Durham, NC 27708.
  • University of Texas, 727 East Dean Keeton St. Austin, Texas 78705.

Förderung

  • NIA NIH HHS

Zitieren

APA

Frakes, M. D., & Wasserman, M. F. (2023). Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination. American Economic Journal: Economic Policy, 15(3), 151-183. https://doi.org/10.1257/pol.20200703

Vancouver

Frakes MD, Wasserman MF. Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination. American Economic Journal: Economic Policy. 2023;15(3):151-183. doi:10.1257/pol.20200703

BibTeX
@article{Frakes2023,
  author = {Frakes, Michael D and Wasserman, Melissa F},
  title = {Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination},
  journal = {American Economic Journal: Economic Policy},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {151--183},
  doi = {10.1257/pol.20200703}
}
Kostenlos starten →